Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

custom synthesis Press Releases

  + XML/RSS  



By Bio-Synthesis, Inc.
Dr. Andrei Laikhter joins management team at Bio-Synthesis, Inc.

By VIO Chemicals
The donation of $25,000 by VIO Chemicals CEO Dimitris Kalisa provides appropriate learning facilities for 262 children in Shwe Myo, Myanmar

By Bio-Synthesis, Inc.
The next generation of nucleic acids, provided by Bio-Synthesis, is an ideal solution for the detection of small or highly similar DNA or RNA targets.

By Bio-Synthesis
Instant Quenchers prove to be a better alternative to BHQ quenchers.

By www.pislife.com
PIS LifeSciences Pvt Ltd Announces production of Prostaglandin’s,Misoprostol Intermediates

By Bio-Synthesis, Inc.
Bio-Synthesis, Inc. has acquired a license from BNA Inc. of Osaka, Japan for the manufacturing and distribution of BNA-NC, a third generation of BNA oligonucleotides.

All Press Releases

By Bio-Synthesis, Inc.
Dr. Andrei Laikhter joins management team at Bio-Synthesis, Inc.

By VIO Chemicals
The donation of $25,000 by VIO Chemicals CEO Dimitris Kalisa provides appropriate learning facilities for 262 children in Shwe Myo, Myanmar

By Bio-Synthesis, Inc.
The next generation of nucleic acids, provided by Bio-Synthesis, is an ideal solution for the detection of small or highly similar DNA or RNA targets.

By Bio-Synthesis
As a community leader in the Dallas-Fort Worth area, Bio-Synthesis helps sponsor the scientific meeting at Texas Women’s University.

By Bio-Synthesis
The annual meeting for the American Associate of Cancer Research will be held April 6-10th in Washington DC.  As always, the meeting will be a platform for new ideas, research, and technologies.

By Bio-Synthesis
Instant Quenchers prove to be a better alternative to BHQ quenchers.

By www.pislife.com
PIS LifeSciences Pvt Ltd Announces production of Prostaglandin’s,Misoprostol Intermediates

By Bio-Synthesis, Inc.
Bio-Synthesis, Inc. has acquired a license from BNA Inc. of Osaka, Japan for the manufacturing and distribution of BNA-NC, a third generation of BNA oligonucleotides.

By biosyn.com
Bio-Synthesis is able to synthesize ultra long oligonucleotides (RNA and DNA).

By Onyx Scientific
Onyx Scientific excel in streamlining GMP synthesis processes. Their compliance standards minimise impurities, reduce costs and significantly improve timelines for phase I and II clinical studies.

By Onyx Scientific Ltd
Custom Synthesis chemistry services CRO, Onyx Scientific, hails the success of its solid-state polymorph screening services for increased process development and GMP synthesis demand

By Onyx Scientific Ltd
Onyx Scientific Ltd, provides solid-form research services throughout all stages of a drug-discovery process, these include: polymorph screening; salt selection; physicochemical property determinations and crystallisation studies.

By Onyx Scientific Ltd
Onyx Scientifics’ solid-state, polymorph screening expertise provides rapid optimization of the physical polymorphic form of a new compound, its physicochemical properties and bioavailability

By Onyx Scientific
Contract research laboratory, Onyx Scientific, provides chemistry services: custom synthesis, process development, lead optimization, GMP synthesis and scale up, automated salt selection, polymorphism screening and solid state analysis

By Bio-Synthesis, Inc.
Bio-Synthesis, Inc., has launched the Peptide Library Generation Software, a versatile platform complete with six powerful screening tools, each designed to help with epitope identification and sequence optimization.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share